Introduction
============

The use of distinct molecular units in the assembly of extended networks has importance in porous metal organic framework (MOF) materials because they have large surface areas, tunable pore sizes, and pore volumes.[@b1-dddt-13-023] Nowadays, gas storage and drug delivery systems are among the most identified applications of MOFs in the industrial and research fields.[@b2-dddt-13-023]--[@b4-dddt-13-023] MOFs have been employed as drug carriers for more than a decade owing to their advantageous properties.[@b5-dddt-13-023] Currently, the most biocompatible metal is iron, which has been employed in the synthesis of different types of MOFs such as MIL100(Fe).[@b4-dddt-13-023],[@b6-dddt-13-023] Employing a pure organic linker or one metal in constructing traditional MOFs is regarded as immobilizing functional sites. However, mixed or multi-MOFs (M-MOFs) are utilized to coordinate further metal ions, which can generate improvement in the pore size and surface area of such materials. This can also immobilize different metal sites such as catalytically active sites or open metal sites for their functional properties.[@b4-dddt-13-023],[@b5-dddt-13-023]

M-MOFs are usually synthesized by adding further metals in the main structure by a direct synthesis or postsynthesis procedures.[@b7-dddt-13-023] The direct synthesis strategy can be achieved by replacing one organic linker by a corresponding derivative[@b8-dddt-13-023] or by employing two different metals that have the same Coulombic charge, ionic radius, and behavior in order to increase the chances of having simultaneous and homogeneous co-incorporation of the two metals.[@b9-dddt-13-023] The postsynthesis strategy is based on the partial replacement of the metal or partial replacement of the linker.[@b10-dddt-13-023]

These materials have demonstrated a high drug loading and controlled release of loaded drugs.[@b11-dddt-13-023] A well-regulated drug delivery system is important to diminish side effects and improve the therapeutic efficacy of drugs. Furthermore, researchers have made significant improvement in the field of drug delivery by MOFs, owing to their simplistic synthesis on a nanoscale and different functional group insertion and surface chemistry.[@b12-dddt-13-023] Drug loading can be achieved by three strategies according to the location of the pay--load and pay-- load--carrier interactions: an encapsulation strategy, direct assembly strategy, and postsynthesis strategy.[@b13-dddt-13-023] Sun et al have proven that mixed ligand MOFs-2 showed the best performance in transporting doxorubicin drug as the consequence of highest loading efficiency even at 48 hours.[@b47-dddt-13-023]

Aceclofenac (ACF) is classified as nonsteroidal anti-inflammatory drug, as shown in [Figure 1](#f1-dddt-13-023){ref-type="fig"}. It has poor water solubility (0.058 µg/mL)[@b14-dddt-13-023] and high permeability, which is regarded as class II according to the biopharmaceutics classification system.[@b15-dddt-13-023] It is widely used to relieve pain and reduce inflammation. The major obstacle for its optimum bioavailability is its intrinsic properties such as poor solubility[@b16-dddt-13-023] and kinetic release profile. Different drug delivery systems have been employed to improve ACF bioavailability, enhance its therapeutic efficacy, and prolong its release.[@b17-dddt-13-023]--[@b20-dddt-13-023] The drug-loading and drug-release processes are mainly ruled by structural parameters of carriers and drug as well as their hydrophobic and hydrophilic properties.[@b21-dddt-13-023]

Controlled drug release systems with appropriate carriers, which include liposomes, dendrimers, micro sponges, microparticles, and micelles, have been employed to increase the therapeutic effectiveness and minimize the side effects of low water-soluble drugs. Several undesired adverse effects, which are accompanied with ACF oral administration, such as gastrointestinal tract (GIT) irritation, ulceration, and bleeding,[@b22-dddt-13-023] are leading the researchers to develop a new drug delivery system to reduce such adverse effects.

In this study, eight samples of M-MIL-100(Fe), Zn I-MIL-100(Fe), Zn II-MIL-100(Fe), Ca I-MIL-100(Fe), Ca II-MIL-100(Fe), Mg I-MIL-100(Fe), Mg II-MIL-100(Fe), Mn I-MIL-100(Fe), and Mn II-MIL-100(Fe) were synthesized, characterized, and evaluated for their application as a drug delivery system to evaluate the loading capacity (LC) of M-MIL-100(Fe) for ACF and define M-MIL-100(Fe) as a potential drug delivery system for ACF.

Materials and methods
=====================

Materials
---------

ACF was purchased from Thermo Fisher Scientific, Waltham, MA, USA. All chemicals such as iron chloride hexahydrate (FeCl~3~.6H~2~O), benzene-1,3,5-tricarboxylic acid (H~2~BTC, C~9~H~6~O~6~), zinc nitrate hexahydrate (Zn (NO~3~)~2~.6H~2~O), calcium nitrate tetra hydrate (Ca (NO~3~)~2~.4H~2~O), magnesium chloride hexahydrate (MgCl~2~.6H~2~O), and manganese chloride hexahydrate (MnCl~2~.6H~2~O) were supplied by Sigma-Aldrich Co. (St Louis, MO, USA) and used without further purification. Ethanol (C~2~H~6~O \>95%) was purchased from Sigma Aldrich and used without further purification. Acetonitrile (C~2~H~3~N 99.9%) and phosphoric acid (H~3~PO~4~ 85%) were supplied from Fisher Scientific, Merelbeke, Belgium.

Synthesis of M-MIL-100(Fe)
--------------------------

A hydrothermal synthesis procedure was used to prepare the M-MIL-100(Fe) samples (Zn I-MIL-100(Fe), Zn II-MIL-100(Fe), Ca I-MIL-100(Fe), Ca II-MIL-100(Fe), Mg I-MIL-100(Fe), Mg II-MIL-100(Fe), Mn I-MIL-100(Fe), and Mn II-MIL-100(Fe)). Symbols I and II refer to the different ratio of a second metal to the iron ion in MIL-100(Fe). The MIL-100(Fe) was prepared by mixing 53.38 mmol of FeCl~3~.6H~2~O with 23.98 mmol of H~3~BTC (trimesic acid) in 36 mL of distilled water inside an autoclave (Teflon-lined autoclave -- 4744 acid digestion bomb -- 125 mL) and heated in an oven at 433 K for 15 hours. Then cooled solution was centrifuged and the solid was washed successively in hot water (350 mL, 343 K, and 3 hours) and in hot ethanol (250 mL, 338 K, and 3 hours). M-MIL-100(Fe) samples were synthesized according to the above procedure using the amount and type of the second metals as described in [Table 1](#t1-dddt-13-023){ref-type="table"}. The salt of a second metal was added to the well mixed solution of parent precursors (FeCL~3~.6H~2~O and H~3~BTC) in H~2~O, then continuously mixed for around 30 minutes. Finally, the solution was transferred to the autoclave and heated in the oven at 433 K for 15 hours; after that, the crystalline product was washed as described above for as synthesized MIL-100(Fe). The obtained orange-brownish powder was dried at 363 K overnight and heated under vacuum at 433 K for 12 hours.[@b23-dddt-13-023]

Characterization
----------------

X-ray powder diffraction (XRPD) was performed using a D8 Advance (Bruker AXS, Karlsruhe, Germany), with a copper Kα radiation source (40 kV and 40 mA) with a Lynx Eye detector. The 2-theta scan range was 5°--20°. NMR spectroscopy (Bruker Advance III 400 MHz spectrometer (Germany) with BBFO Plus multi-nuclei probe and low and high temperature capability). Nuclear magnetic resonance (NMR) spectra were referenced to their solvents: deuterium oxide (D~2~O, 1H, δ 4.79 ppm). Textural properties of M-MIL-100(Fe) were characterized by N~2~ adsorption--desorption isotherms, which were obtained at 77 K using a micromeritics, TriStar-3020 instrument, to determine the specific surface area, pore size, and volume. In brief, a 100 mg of the sample was first dried at 373 K in an oven and then it was degassed by Vac Prep™ 061 at 433 K overnight. Finally, the degassed sample was used in the TriStar instrument for analysis after getting the net weight of the sample. Fourier transform infrared spectra (FTIR) were obtained using a PerkinElmer FTIR spectrometer in the range of 650--4,000 cm^−1^. The morphological description was achieved by using a Zeiss Neon 40EsB FESEM. Zeta potential was determined by a Zeta sizer Nano-ZS (Malvern Instruments, Malvern, UK) at 298 K. More specifically, the materials were mixed with distilled water and stirred for 1 hour to be suspension system at constant temperature (298 K) and then was examined.

Loading of ACF with M-MIL-100(Fe)
---------------------------------

The ACF calibration assay was analyzed by HPLC (Shimadzu 20 AC), and the mobile phase was 50 mmol phosphate buffer solution at pH 6.8 with acetonitrile 30% at a range of ACF concentrations (10, 20, 30, 40, 50, and 60 µg/mL) in ethanol (95%). The L-max was 274 and the flow rate was 1.5 mL/min.

A sample of 40 mg of ACF was dissolved in 10 mL of 60% ethanol to make solution of 4 mg/mL and analyzed by HPLC to determine the amount of ACF before loading. A sample of 40 mg of predried M-MIL-100(Fe) at 393 K for 6 hours was loaded in the ACF solution in 20 mL glass containers. After sealing the container tightly, the mixture was stirred (at 150 rpm) for 24 hours at room temperature by a magnetic stirrer. The supernatant was collected after centrifugation (4,000 rpm, 15 minutes), diluted, and analyzed by HPLC to determine the remaining amount of ACF in the solution after loading. The remaining solid material in the bottom of the centrifuge tube was dried overnight at 333 K in an oven. The loading amount of ACF was calculated by subtracting the amount of ACF in the supernatant solution from the amount of ACF before loading. The entrapment efficiency (EE), which is the percentage adsorbed at the surface of M-MIL-100(Fe), was determined using [Equation 1](#fd1-dddt-13-023){ref-type="disp-formula"} $$\%\text{EE} = \frac{\text{Weight-loaded}\ \text{ACF~}(\text{mg})}{\text{ACF~before~loading~}(\text{mg})} \times 100$$

The LC of M-MOFs was calculated by employing [Equation 2](#fd2-dddt-13-023){ref-type="disp-formula"} $$\%\text{LC} = \frac{\text{Weight-loaded}\ \text{ACF~}(\text{mg})}{\text{Weight~of~loaded~M} - \text{MOF~}(\text{mg})} \times 100$$

ACF release profiles
--------------------

Release profiles used a dissolution tester (Erweka DT6 unit). A predetermined quantity of loaded M-MIL-100-(Fe) accurately weighed was submerged into 1,000 mL of dissolution medium (50 mmol PBS at either pH 7.4 or 6.8 in the dissolution vessel maintained at 37°C ± 1°C with constant stirring at 75 rpm). At predetermined time intervals (0.25, 0.5, 1.5, 4, 5, 6, 12, 24, 30, 48, and 72 hours), an aliquot of 5 mL was withdrawn and replaced with the same volume of fresh dissolution medium. The aliquots were diluted and filtered by 0.2 µm syringe filter and analyzed using HPLC. All experimental results were triplicate and the standard deviation was calculated. A correction of the ACF amount in dissolution medium extracted was calculated regarding the ACF lost in each aliquot. The released percentage of ACF was calculated according to [Equation 3](#fd3-dddt-13-023){ref-type="disp-formula"} $$\text{Release} = \frac{\text{Actual~ACF~released~at~any~time~}(\text{mg})}{\text{Theoretical~ACF~amount~loaded~}(\text{mg})} \times 100$$

Results and discussion
======================

[Figure 2A--D](#f2-dddt-13-023){ref-type="fig"} shows XRPD profiles for loaded and unloaded M-MIL-100. Diffraction profiles of M-MIL-100(Fe) and ACF\@M-MIL-100(Fe) samples had similar structures as of MIL-100(Fe). However, the crystallinity of ACF\@M-MIL-100 was noticeably decreased when compared with the unloaded M-MIL-100(Fe). The peak intensities of loaded M-MIL-100(Fe) were reduced while the peak positions in the XRPD patterns were similar for the MIL-100(Fe) and the corresponding unloaded MIL-100(Fe). The XRPD of different structures of M-MIL-100 showed a possible stable framework, which indicates qualitatively ACF loading and the integrity of M-MIL-100(Fe) structures after ACF loading.[@b10-dddt-13-023]

Thermal stability of all samples was similar to that of main structure of MIL-100(Fe). The structure collapsed when the temperature was raised to about 580 K as shown in [Figure S1](#SD1-dddt-13-023){ref-type="supplementary-material"}. In addition, the morphological descriptions are shown in [Figure S2](#SD2-dddt-13-023){ref-type="supplementary-material"}. It seems that particle size was similar in all samples except in Zn-MIL-100(Fe) samples where the particles were enlarged. This is due to adding Zn^2+^ to the MIL100(Fe). It seems that zinc salt might lead to slowing down of the nanocrystal nucleation process and growing up of the particles size to be larger specially in the presence of water as a solvent in the synthesis procedure. This is related to the high deliquescent property of zinc nitrate hexahydrate.[@b24-dddt-13-023],[@b25-dddt-13-023] Although the particle size commonly used for drug delivery was less than 100 nm, the sizes of particles ranged from 100 to 250 nm are also preferred in drug delivery system. Hence, it can be confirmed that the drug can be delivered to the specific organ or tissue in the desired final dose.[@b26-dddt-13-023] [Figure S3](#SD3-dddt-13-023){ref-type="supplementary-material"} shows that functional groups on the surfaces of the pores were maintained in M-MIL-100(Fe) samples as in MIL-100(Fe).

The N~2~ adsorption--desorption isotherms for all M-MIL-100(Fe) samples are shown in [Figure 3](#f3-dddt-13-023){ref-type="fig"}. The resultant pore size, surface area, and pore volume are shown in [Table 2](#t2-dddt-13-023){ref-type="table"}. This indicates that the content of a second metal in the final product was varied and dependent on the type of metal. In addition, a lower proportion of the second metal was investigated in the final product in compared to the first metal (Fe^3+^). The nonconjoined metal may affect the pore size, pore volume, and surface area as it can play a prominent role as a template beside the solvent in the synthesis process. Consequently, it can be seen that the isotherms are vertical at pressures close to 1 atm, indicating that all samples had significantly higher pore size and pore volume than MIL-100(Fe).[@b27-dddt-13-023] Specifically, increasing the content of the second metal increased pore volume to at least double that of the parent MIL-100(Fe). The maximum pore volume displayed with Ca II-MIL-100(Fe), Zn I-MIL-100(Fe), and Zn II-MIL-100(Fe) was 1.17, 1, and 1.04 cm^3^/g, respectively. In addition, the maximum diameter was doubled in MnI-MIL-100(Fe) and Mn II-MIL-100-(Fe). However, the surface area consequently was reduced in M-MIL-100(Fe) (Mn^2+^, Mg^2+^, Zn^2+^) samples below MIL-100(Fe), while it declined in Ca I-MIL-100(Fe) and increased to 1,848.45 m^2^/g in Ca II-MIL-100(Fe). This can be attributed to that each metal has different coordination environment, different ionic radius, different coordination geometry, and different affinity to exchange by solvent exchange method. When a second metal has different ionic radius, different valence number, and different coordination geometry, it can occupy vacant metal sites in the main metal cluster.[@b28-dddt-13-023]--[@b30-dddt-13-023] Therefore, an increase in the size of ions might lead to increase in lattice disorder.[@b31-dddt-13-023] More specifically, activation by solvent exchange process followed by heating at 433 K leads to removal of a second metal from the occupied metal site or removal of the whole metal cluster, which increases the structural defects, and consequently the pore volume and size are enhanced.[@b32-dddt-13-023],[@b33-dddt-13-023]

Hence the successively incorporating a metal ion followed by desolvation can significantly change the textural properties, which in turn can affect the drug adsorption properties.[@b34-dddt-13-023] Significantly, increasing the pore diameter \>2 nm was observed in all M-MIL-100(Fe) samples; therefore, controlled drug delivery can be enhanced.[@b6-dddt-13-023]

The ACF LC and EE were same values because the weights of the M-MIL-100(Fe) and ACF before mixing were equal. The LC and EE showed a significant increment for all M-MIL-100(Fe) samples in comparison to the MIL-100(Fe), which is a single metal ion, as shown in [Table 2](#t2-dddt-13-023){ref-type="table"}. The ACF LC of MIL-100(Fe) was 27%, whereas the LC of M-MOFs significantly increased to 37% with Ca I-MIL-100(Fe) and more than doubled (57% and 59%) when Mn II-MIL-100(Fe) and Zn II-MIL-100(Fe) were, respectively, employed. These results demonstrated the effects of diversity in the pore and volume sizes and surface area of M-MOFs as shown in [Table 2](#t2-dddt-13-023){ref-type="table"}. The type and percentage of a second metal incorporated with an organic linker alongside with the Fe ion have a major role in the modification of the functionalized site in the M-MOF and consequently improving its textural characterization.[@b35-dddt-13-023] The lowest LC of M-MOF was 37%, which occurred with Ca I-MIL-100-(Fe), and that can be related to the lowest pore volume (0.67 cm^3^/g) and surface area (1,078.82 m^2^/g), while the pore volume and surface area of Ca II-MIL-100(Fe) (1.17 cm^3^/g and 1,848.45 m^2^/g, respectively) have demonstrated increased LC (50%). All other M-MIL-100(Fe) type II demonstrated higher loading capacities of ACF as compared to the type I. This can be related to the increased pore size, pore volume, or surface area of M-MIL-100(Fe), which is the effect of the second metal within MOF. Increasing the pore size or volume can improve the mobility of the drug molecules within the pores by uniformly increasing the diffusion rate in the case of loading and release of the drug.[@b36-dddt-13-023] The highest ACF LC (59%) was with Zn II-MIL-100(Fe) owing to the increased pore size and volume and in addition to the surface area of Zn II-MIL-100(Fe) (2.61 nm, 1.04 cm^3^/g, and 1,590.46 m^2^/g, respectively). It was previously shown that MOFs adsorb drastically different amounts of drug as a result of their different pore volumes and pore sizes.[@b6-dddt-13-023],[@b23-dddt-13-023] No previous study has demonstrated ACF loading with MOF; however, this study shows a significant loading of ACF on MOF while the results in previous report showed that a maximum LC of diclofenac within Zhejiang University (ZJU)-101 MOF was accomplished with a rate up to \~50%.[@b37-dddt-13-023]

The NMR analysis showed ACF loading in [Figure 4](#f4-dddt-13-023){ref-type="fig"}. The loading area is represented by the green labeling, which is located between 6.3 and 7.5 ppm as shown in [Figure 4](#f4-dddt-13-023){ref-type="fig"}. Presence of aromatic amide in the ACF molecule has resonance at 7 theta degree, which shows ACF was protonated and refers to the chemical stability of the adsorbed drug in the pores. This spectrum of resonance was same for all loaded M-MIL-100(Fe) samples.[@b38-dddt-13-023],[@b39-dddt-13-023]

Zeta potential measurements were obtained to confirm the loading event and stability of nanoparticles of M-MIL-100(Fe) and ACF\@M-MIL-100(Fe) because the surface charge of the particles and binding force types between the molecules of the drug and the nanoparticles are the most important parameters to approve the drug loading efficiency and the release rate of drug.[@b40-dddt-13-023] Zeta potential measurements of ACF\@M-MIL-100(Fe) were positively increased in comparison to the bare M-MIL-100(Fe) as shown in [Table 3](#t3-dddt-13-023){ref-type="table"}. This result indicated the loading of ACF within M-MIL-100(Fe) and the interaction between carboxyl groups of the organic linker of M-MIL-100(Fe) samples with hydroxyl group of ACF to form ester bond. Therefore, the negativity of the carboxylic group in all M-MIL-100(Fe) samples was reduced although the changes were small. The binding type and the rate of drug loading on the surface of nanoparticles can be determined by the surface charge of the MOF and hydrophobicity of the drug. By measurement of the zetapotential of the MOF before and after loading, one can determine if the drug is adsorbed or not due to electrostatic interaction between charged block of MOF and oppositely charged drug, which has allowed the formation of core--shell, and in this way, loading efficiency will be improved.[@b41-dddt-13-023]

The release profiles of ACF were achieved in the simulated GIT and plasma medium of phosphate buffer solutions at either pH 6.8 or 7.4. The ACF release profiles are shown in [Figure 5A--D](#f5-dddt-13-023){ref-type="fig"} for all ACF\@M-MIL-100(Fe) samples.

The release profiles of ACF in both medium demonstrate a slower release-rate profile of ACF\@M-MIL-100(Fe) as compared to the ACF\@MIL-100(Fe) whether at pH 6.8 or 7.4. There was also a reduction in the release rate in pH 6.8 medium in comparison with 7.4. The release profiles show a difference in the rate of release according to the type of the second metal employed in the M-MIL-100(Fe). Although it was known that the release rate can be enhanced by increasing the pore size,[@b42-dddt-13-023] the release of ACF from Zn I-MIL-100(Fe) and II was slower in comparison to others. The total amounts of the ACF released were between 91% with ACF\@MIL-100(Fe) and 75% for ACF\@Zn II-MIL-100(Fe) at pH 6.8. The slow release profile at pH 6.8 phosphate buffer medium can be related to the dissolution rate of ACF at this pH and the strength of the interaction of ACF within the pores at the surface of M-MOF molecule.[@b43-dddt-13-023],[@b44-dddt-13-023] The solubility of ACF and consequently its dissolution rate depends on the pKa of ACF (4.7) and the pH of the medium therefore the release rate of ACF at pH 6.8 medium was slower as comparison to the pH 7.4 medium. The slow release of ACF\@Zn I-MIL-100(Fe) and Zn II-MIL-100(Fe) may be related to the competition between the phosphate buffer medium and the strength of interaction of the ACF within the pores of M-MIL-100-(Fe).[@b45-dddt-13-023] Also, it may be attributed to the partial degradation in the presence of heavier phosphate anions adsorbed on the porous framework. Hence, progressive ACF release from MIL-Fe(100) solid would be mostly governed by a controlled diffusion of the ACF through the slightly amphiphilic pores. The rapid release in the first stage of dissolution process may be related to the slow collapsing of the MOF structure in the phosphate buffer solution with replacement of the carboxylate linkers by phosphate groups.[@b46-dddt-13-023]

Conclusion
==========

The second metal was successfully incorporated with base metal. A low concentration of the second metal was investigated in the final product although a high concentration was used in the synthesis procedure. It seems smaller amounts of the second metal (Ca^2+^, Mn^2+^, Mg^2+^, and Zn^2+^) were incorporated in metal center of MIL-100(Fe), and the remaining amount worked as a template. Therefore, the textural properties were improved toward enhancing the pore size and pore volume. The drug LC was doubled in comparison to the bare MIL-100(Fe). The release-rate profile of ACF was promising as a sustained release of the drug. These MOFs have a typical nanoparticle size and high stability with high loading and very good release rate so that they are promising materials for drug delivery systems.

Supplementary materials
=======================

###### 

TGA profiles of M-MIL-100(Fe) (where M is either Ca, Mg, Mn, or Zn).

###### 

SEM images of MIL-100(Fe) and all M-MILs-100(Fe).

**Notes:** Ca I-MIL-100(Fe) (**A**), Ca II-MIL-100(Fe) (**B**), Mg I-MIL-100(Fe) (**C**), Mg II-MIL-100(Fe) (**D**), Mn I-MIL-100(Fe) (**E**), Mn II-MIL-100(Fe) (**F**), Zn I-MIL-100(Fe) (**G**), Zn II-MIL-100(Fe) (**H**), and MIL-100(Fe) (**I**).

###### 

FTIR spectra for M-MIL-100(Fe) (where M is either Ca, Mn, Mg, or Zn) samples.

**Abbreviation:** FTIR, Fourier transform infrared.
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![The chemical structure of aceclofenac.](dddt-13-023Fig1){#f1-dddt-13-023}

![XRPD of MIL-100(Fe) and M-MIL-100(Fe) samples (where M is either Ca (**A**), Mg (**B**), Mn (**C**), or Zn (**D**)).\
**Abbreviation:** XRPD, X-ray powder diffraction.](dddt-13-023Fig2){#f2-dddt-13-023}

![N~2~ adsorption--desorption isotherms for MIL-100(Fe) (**A**) and M-MIL-100(Fe) (M is Ca (**B**), Mn (**C**), Mg (**D**), or Zn (**E**)) samples.](dddt-13-023Fig3){#f3-dddt-13-023}

![NMR of ACF and corresponding M-MIL-100(Fe) samples (ACF and Ca-M-MIL-(Fe) I and II) (**A**), (ACF and Mg-MIL-100(Fe-) I and II) (**B**), (ACF and Mn-MIL-100(Fe) I and II) (**C**), and (ACF and Zn-MIL-100(Fe) I and II) (**D**).\
**Abbreviations:** ACF, aceclofenac; NMR, nuclear magnetic resonance.](dddt-13-023Fig4){#f4-dddt-13-023}

![The release profiles of (**A**--**D**) represent all ACF\@M-MIL-100(Fe) (Zn, Mn, Mg, and Ca, respectively) samples in 50 mmol phosphate buffer (pH 6.8 and 7.4) at 37°C±1°C.\
**Abbreviation:** ACF, aceclofenac.](dddt-13-023Fig5){#f5-dddt-13-023}

###### 

Materials and the ratio of metal ions used in the M-MIL-100(Fe) synthesis

  M-MOF                 Metal-based materials   Amount used in the synthesis   Molar ratio% (M^2+^/Fe^3+^)
  --------------------- ----------------------- ------------------------------ -----------------------------
                                                                               
  Zn I-MIL-100(Fe)      FeCl~3~.6H~2~O          14.43 g (53.3 mmol)            9.9
  Zn(NO~3~)~2~.6H~2~O   1.59 g (5.3 mmol)                                      
  Zn II-MIL-100(Fe)     FeCl~3~.6H~2~O          10.50 g (38.0 mmol)            70
  Zn(NO~3~)~2~.6H~2~O   7.94 g (26.6 mmol)                                     
  Ca I-MIL-100(Fe)      FeCl~3~.6H~2~O          10.70 g (39.9 mmol)            13.2
  Ca(NO~3~)~2~.4H~2~O   1.26 g (5.3 mmol)                                      
  Ca II-MIL-100(Fe)     FeCl~3~.6H~2~O          10.69 g (39.5 mmol)            67.3
  Ca(NO~3~)~2~.4H~2~O   6.29 g (26.6 mmol)                                     
  Mg I-MIL-100(Fe)      FeCl~3~.6H~2~O          14.43 g (53.3 mmol)            11.2
  Mgcl~2~.6H~2~O        1.22 g (6.0 mmol)                                      
  Mg II-MIL-100(Fe)     FeCl~3~.6H~2~O          10.45 g (38.6 mmol)            77.7
  Mgcl~2~.6H~2~O        6.10 g (30.0 mmol)                                     
  Mn I-MIL-100(Fe)      FeCl~3~.6H~2~O          14.43 g (53.3 mmol)            9.4
  MnCl~2~.6H~2~O        1.22 g (5.0 mmol)                                      
  Mn II-MIL-100(Fe)     FeCl~3~.6H~2~O          10.45 g (38.6 mmol)            67.3
  MnCl~2~.6H~2~O        6.10 g (26 mmol)                                       

**Abbreviation:** M-MOF, multimetal organic framework.

###### 

Textural properties of MIL-100(Fe) and M-MIL-100(Fe) and loading percentages of ACF

  MIL                 M/Fe % final product   Surface area ± SD m^2^/g   Pore size ± SD nm   Pore volume ± SD cm^3^/g   LC% ± SD   EE% ± SD
  ------------------- ---------------------- -------------------------- ------------------- -------------------------- ---------- ----------
                                                                                                                                  
  MIL-100(Fe)         0                      1,604±5.0                  1.29±0.09           0.52±0.02                  27±1.9     27±1.9
  Ca I-MIL-100(Fe)    0.38                   1,078±7.9                  2.48±0.04           0.67±0.03                  37±2.1     37±2.1
  Ca II-MIL-100(Fe)   1.75                   1,848±6.6                  2.53±0.05           1.17±0.03                  50±2.2     50±2.2
  Mg I-MIL-100(Fe)    0.04                   1,508±8.4                  2.33±0.02           0.88±0.05                  47±1.1     47±1.1
  Mg II-MIL-100(Fe)   0.55                   1,384±6.9                  2.74±0.02           0.95±0.04                  51±3.3     51±3.3
  Mn I-MIL-100(Fe)    0.11                   1,272±3.0                  2.89±0.04           0.92±0.01                  45±2.8     45±2.8
  Mn II-MIL-100(Fe)   0.45                   1,305±10.0                 2.88±0.07           0.94±0.06                  57±2.4     57±2.4
  Zn I-MIL-100(Fe)    0.07                   1,499±7.9                  2.67±0.06           1.00±0.07                  49±1.7     49±1.7
  Zn II-MIL-100(Fe)   0.17                   1,590±9.9                  2.61±0.06           1.04±0.04                  59±2.5     59±2.5

**Abbreviations:** ACF, aceclofenac; EE, entrapment efficiency; LC, loading capacity.

###### 

Zeta potential values of all M-MIL-100(Fe) and ACF\@M-MIL-100(Fe)

  MOF                      Zeta potential (mV) ± SD
  ------------------------ --------------------------
                           
  MIL-100(Fe)              −18.9±0.2
  ACF\@MIL-100(Fe)         −12.0±1.0
  Ca I-MIL-100(Fe)         −21.5±0.8
  ACF\@Ca I-MIL-100(Fe)    −12.2±1.1
  Ca II-MIL-100(Fe)        −9.97±0.9
  ACF\@Ca II-MIL-100(Fe)   −12.6±0.3
  Mg I-MIL-100(Fe)         −14.7±0.7
  ACF\@Mg I-MIL-100(Fe)    −12.3±0.2
  Mg II-MIL-100(Fe)        −15.7±0.7
  ACF\@Mg II-MIL-100(Fe)   −10.1±0.9
  Mn I-MIL-100(Fe)         −18.5±0.8
  ACF\@Mn I-MIL-100(Fe)    −11.7±1.0
  Mn II-MIL-100(Fe)        −19.4±0.6
  ACF\@Mn II-MIL-100(Fe)   −11.5±0.5
  Zn I-MIL-100(Fe)         −18.1±0.1
  ACF\@Zn I-MIL-100(Fe)    −11.8±0.5
  Zn II-MIL-100(Fe)        −18.0±0.5
  ACF\@Zn II-MIL-100(Fe)   −13.2±0.2

**Note:** ±SD, n=3.

**Abbreviations:** ACF, aceclofenac; MOF, metal organic framework.
